Identifiability of PBPK models with applications to dimethylarsinic acid exposure.
about
Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical DataEvaluation and calibration of high-throughput predictions of chemical distribution to tissues.Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics.Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.What do we mean by identifiability in mixed effects models?Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling.
P2860
Identifiability of PBPK models with applications to dimethylarsinic acid exposure.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identifiability of PBPK models with applications to dimethylarsinic acid exposure.
@en
type
label
Identifiability of PBPK models with applications to dimethylarsinic acid exposure.
@en
prefLabel
Identifiability of PBPK models with applications to dimethylarsinic acid exposure.
@en
P2093
P2860
P1476
Identifiability of PBPK models with applications to dimethylarsinic acid exposure.
@en
P2093
Joseph G Ibrahim
R Woodrow Setzer
Ramon I Garcia
P2860
P2888
P304
P356
10.1007/S10928-015-9424-2
P577
2015-07-21T00:00:00Z